‘Crisis over’ for Bayer MaterialScience

Revenues rose 14.6% to €9.2bn, up from €8bn, due largely to growth in its consumer health and high-tech materials divisions. But total earnings of €525m in the April to June period were down from €532m for the same period the previous year as a result of the one-off hits.

“MaterialScience has left the crisis behind and saw business expand more strongly than expected. Volumes have returned to the pre-crisis level,” said Bayer chairman Werner Wenning.

Bayer's MaterialScience division posted a very strong rise in quarterly revenue – up 46.9% to €2.7bn. Sales at HealthCare, meanwhile, improved slightly, while the subgroup’s earnings matched the prior-year level. CropScience was down year-on-year. That subgroup saw volumes and selling prices decline in a market environment made difficult by the competitive situation and unfavourable weather conditions.

[ Back ]